A Japanese Designated Marketing Authorization Holder (DMAH) is a local entity responsible for obtaining and maintaining marketing authorization for foreign pharmaceutical companies in Japan. The DMAH ensures compliance with Japanese regulations, manages product registrations, and acts as the liaison between the foreign manufacturer and Japanese regulatory authorities.